FDA advisers to vote on Pfizer's COVID-19 booster shots
Their vote isn't binding, but it's a key step toward allowing a third dose of Pfizer's vaccine in the U.S.
Their vote isn't binding, but it's a key step toward allowing a third dose of Pfizer's vaccine in the U.S.